New glaucoma progression predictors

Article

Lower systolic perfusion pressure, lower systolic blood pressure and cardiovascular disease history are all predictors of glaucoma.

Lower systolic perfusion pressure, lower systolic blood pressure and cardiovascular disease history are all predictors of glaucoma, according to a study published online ahead of print by Ophthalmology.

Researchers from the Early Manifest Glaucoma Trial (EMGT) examined the progression criteria of patients with early open-angle glaucoma (OAG). A total of 255 patients with OAG were randomized to be treated with argon laser trabeculoplasty plus betaxolol (n=129) or to receive no immediate treatment (n=126). Subjects were examined every three months for up to 11 years in some cases.

The researchers discovered that lower systolic perfusion pressure, lower systolic blood pressure and cardiovascular disease history are all predictors of glaucoma, suggesting a vascular role in glaucoma progression. Another new factor discovered was thinner central corneal thickness (CCT), with results suggesting a preferential CCT effect with higher IOP.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.